Spectrum: Assertio Allegedly Overstated Impact of Spectrum Acquisition
Assertio Holdings Inc. and two top executives oversold the impact the company's acquisition of Spectrum Pharmaceuticals Inc. would have on profitability, according to a shareholder class action complaint.
Read full article »
Spectrum is a Nevada-based biopharmaceutical company that acquires, develops and commercializes novel therapeutics for the treatment of cancer.
Read more